Order Article Reprints

Sagredou S, Dalezis P, Papadopoulou E, Voura M, Deligiorgi MV, Nikolaou M, Panayiotidis MI, Nasioulas G, Sarli V, Trafalis DT. Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. Pharmaceutics. 2021; 13(6):885. https://doi.org/10.3390/pharmaceutics13060885

Sagredou, Sofia, Panagiotis Dalezis, Eirini Papadopoulou, Maria Voura, Maria V. Deligiorgi, Michail Nikolaou, Mihalis I. Panayiotidis, George Nasioulas, Vasiliki Sarli, and Dimitrios T. Trafalis. 2021. "Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden" Pharmaceutics 13, no. 6: 885. https://doi.org/10.3390/pharmaceutics13060885

Sagredou, S., Dalezis, P., Papadopoulou, E., Voura, M., Deligiorgi, M. V., Nikolaou, M., Panayiotidis, M. I., Nasioulas, G., Sarli, V., & Trafalis, D. T. (2021). Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. Pharmaceutics, 13(6), 885. https://doi.org/10.3390/pharmaceutics13060885